SELECT THERAPEUTICS INC
10QSB/A, EX-27, 2000-11-22
PHARMACEUTICAL PREPARATIONS
Previous: SELECT THERAPEUTICS INC, 10QSB/A, 2000-11-22
Next: FINANTRA CAPITAL INC, 10QSB/A, 2000-11-22



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This  schedule  contains  summary  financial   information  extracted  from  the
consolidated financial statements for the nine months ended March 31, 2000 and
is qualified in its entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-START>                             JUL-01-1999
<PERIOD-END>                               MAR-31-2000
<CASH>                                       8,872,017
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                     22,805
<CURRENT-ASSETS>                             8,913,602
<PP&E>                                         174,408
<DEPRECIATION>                                  61,971
<TOTAL-ASSETS>                               9,731,808
<CURRENT-LIABILITIES>                          553,274
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         1,186
<OTHER-SE>                                   9,177,348
<TOTAL-LIABILITY-AND-EQUITY>                 9,731,808
<SALES>                                        170,590
<TOTAL-REVENUES>                               171,114
<CGS>                                           56,902
<TOTAL-COSTS>                                   56,902
<OTHER-EXPENSES>                             3,186,800
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                             (3,072,588)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                         (3,072,588)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (3,072,588)
<EPS-BASIC>                                     (0.44)
<EPS-DILUTED>                                   (0.44)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission